Advertisement

Supply Chain



Although President Donald Trump promised May 31 pharmaceutical companies would announce "massive" drug price cuts, drugmaker Bayer increased the list prices of two cancer drugs by more than $1,000 per month, according to The Washington Post.

Here are the three latest drugs approved by the FDA since June 1.

Advertisement

Most Read

Advertisement
Advertisement